Difference between revisions of "Anastrozole (Arimidex)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replace - "package insert<ref name="insert"></ref>." to "prescribing information.<ref name="insert"></ref>")
m (updated diseases)
Line 1: Line 1:
 
==General information==
 
==General information==
Class/mechanism: Selective non-steroidal aromatase inhibitor.  The aromatase enzyme converts adrenal and ovarian androgens (androstenedione and testosterone) to estrogens (estrone and estradiol) in peripheral tissues.<ref name="insert">[http://www1.astrazeneca-us.com/pi/arimidex.pdf Anastrozole (Arimidex) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/anastrozole.pdf Anastrozole (Arimidex) package insert (locally hosted backup)]</ref>
+
Class/mechanism: Selective non-steroidal aromatase inhibitor.  The aromatase enzyme converts adrenal and ovarian androgens (androstenedione and testosterone) to estrogens (estrone and estradiol) in peripheral tissues.<ref name="insert">[http://www1.astrazeneca-us.com/pi/arimidex.pdf Anastrozole (Arimidex) package insert]</ref><ref>[[Media:Anastrozole.pdf | Anastrozole (Arimidex) package insert (locally hosted backup)]]</ref><ref>[http://www.arimidex.com/ Arimidex manufacturer's website]</ref>
 
<br>Route: PO
 
<br>Route: PO
 
<br>Extravasation: n/a
 
<br>Extravasation: n/a
  
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
 
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref>
 +
 +
==Diseases for which it is used==
 +
*[[Breast cancer]]
 +
*[[Uterine cancer]]
  
 
==Patient drug information==
 
==Patient drug information==
 +
*[http://www1.astrazeneca-us.com/pi/arimidex.pdf#page=10 Anastrozole (Arimidex) package insert PDF pages 10-11]<ref name="insert"></ref>
 
*[http://chemocare.com/bio/anastrozole.asp Anastrozole (Arimidex) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/anastrozole.asp Anastrozole (Arimidex) patient drug information (Chemocare)]</ref>
 
*[http://chemocare.com/bio/anastrozole.asp Anastrozole (Arimidex) patient drug information (Chemocare)]<ref>[http://chemocare.com/bio/anastrozole.asp Anastrozole (Arimidex) patient drug information (Chemocare)]</ref>
 
*[http://www.uptodate.com/contents/anastrozole-patient-drug-information Anastrozole (Arimidex) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/anastrozole-patient-drug-information Anastrozole (Arimidex) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/anastrozole-patient-drug-information Anastrozole (Arimidex) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/anastrozole-patient-drug-information Anastrozole (Arimidex) patient drug information (UpToDate)]</ref>
 
==Regimen==
 
Anastrozole (Arimidex) 1mg PO daily (adjuvant, locally advanced, metastatic breast cancer)
 
  
 
==References==
 
==References==
 
<references/>
 
<references/>

Revision as of 15:47, 17 September 2012

General information

Class/mechanism: Selective non-steroidal aromatase inhibitor. The aromatase enzyme converts adrenal and ovarian androgens (androstenedione and testosterone) to estrogens (estrone and estradiol) in peripheral tissues.[1][2][3]
Route: PO
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Patient drug information

References